Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
about
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bands.Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.Neurofilaments as biomarkers in multiple sclerosis.Clinical biomarkers in multiple sclerosis.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.Cerebrospinal fluid analysis and the determination of oligoclonal bands.miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.
P2860
Q28270642-792CFC5A-1825-4698-B6C0-7FDA626D0BE8Q34170448-CDDD0F01-D415-4565-AE8A-5DC02BCDF478Q34423587-D9245A26-0894-4864-8B5A-B45CA5A49861Q34457797-F0EC6E63-8521-4246-AF2B-52113BFBF705Q36887316-557B4D21-8584-4958-8E12-11298ECF9F49Q38001602-189C18B5-2F47-4300-B0DB-FDCD44DC89A6Q38088728-1C7735C3-57D1-430F-B4E7-AE0045697249Q38088747-09F6EAF3-A5AD-4ACC-93AB-2E7A78D94DE2Q39027028-4F5728E4-EB94-42C3-93ED-3C9C96C71F52Q44681284-209FDBC6-1EB3-4C52-B0CC-D2725E23CA17Q47186219-17EEFD09-59B6-4DA1-B7AA-D923DDF05167Q48170019-E6CC3383-4CE7-4D26-B75D-A8337C4BCFFFQ48482480-B50CFB1A-5DEC-4803-B1F2-73C6F32CDC80Q50067490-39AE91AC-C82A-4535-A08F-C6657BE09780Q50219487-11E5696A-E6E1-46A8-B80C-6F0B0D189B45
P2860
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@en
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@nl
type
label
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@en
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@nl
prefLabel
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@en
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@nl
P2093
P2860
P356
P1476
Lipid-specific immunoglobulin ...... outcome in multiple sclerosis.
@en
P2093
A K Hedström
J C Alvarez-Cermeño
M Thangarajh
T Masterman
P2860
P304
P356
10.1177/1352458508095729
P577
2008-08-28T00:00:00Z